- Home
- TPCS vs ANVS Comparison
TPCS vs ANVS Comparison
Compare TPCS & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPCS
- ANVS
- Stock Information
- Founded
- TPCS 1956
- ANVS 2008
- Country
- TPCS United States
- ANVS United States
- Employees
- TPCS N/A
- ANVS N/A
- Industry
- TPCS Metal Fabrications
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- TPCS Industrials
- ANVS Health Care
- Exchange
- TPCS Nasdaq
- ANVS Nasdaq
- Market Cap
- TPCS 51.4M
- ANVS 46.1M
- IPO Year
- TPCS N/A
- ANVS 2020
- Fundamental
- Price
- TPCS $4.90
- ANVS $2.21
- Analyst Decision
- TPCS
- ANVS Strong Buy
- Analyst Count
- TPCS 0
- ANVS 4
- Target Price
- TPCS N/A
- ANVS $17.33
- AVG Volume (30 Days)
- TPCS 29.6K
- ANVS 1.3M
- Earning Date
- TPCS 08-21-2025
- ANVS 11-07-2025
- Dividend Yield
- TPCS N/A
- ANVS N/A
- EPS Growth
- TPCS N/A
- ANVS N/A
- EPS
- TPCS N/A
- ANVS N/A
- Revenue
- TPCS $33,424,000.00
- ANVS N/A
- Revenue This Year
- TPCS N/A
- ANVS N/A
- Revenue Next Year
- TPCS N/A
- ANVS N/A
- P/E Ratio
- TPCS N/A
- ANVS N/A
- Revenue Growth
- TPCS 3.78
- ANVS N/A
- 52 Week Low
- TPCS $2.05
- ANVS $1.11
- 52 Week High
- TPCS $6.25
- ANVS $10.54
- Technical
- Relative Strength Index (RSI)
- TPCS 42.10
- ANVS 51.88
- Support Level
- TPCS $4.72
- ANVS $1.90
- Resistance Level
- TPCS $5.41
- ANVS $2.21
- Average True Range (ATR)
- TPCS 0.29
- ANVS 0.18
- MACD
- TPCS -0.07
- ANVS 0.02
- Stochastic Oscillator
- TPCS 18.42
- ANVS 56.23
About TPCS TechPrecision Corporation Common stock
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.